Second Sight Medical Products Company Profile (NASDAQ:EYES)

About Second Sight Medical Products

Second Sight Medical Products logoSecond Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. It does not restore normal vision and it does not slow or reverse the progression of the disease. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The Argus II System works by converting video images captured by a miniature camera housed in a patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EYES
  • CUSIP:
Key Metrics:
  • Previous Close: $3.25
  • 50 Day Moving Average: $3.50
  • 200 Day Moving Average: $4.12
  • 52-Week Range: $3.17 - $8.48
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.64
  • P/E Growth: 0.00
  • Market Cap: $137.15M
  • Outstanding Shares: 42,199,000
  • Beta: 3.85
Profitability:
  • Net Margins: -366.25%
  • Return on Equity: -103.44%
  • Return on Assets: -77.69%
Debt:
  • Current Ratio: 5.40%
  • Quick Ratio: 4.18%
Additional Links:
Companies Related to Second Sight Medical Products:

Analyst Ratings

Consensus Ratings for Second Sight Medical Products (NASDAQ:EYES) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.50 (455.56% upside)

Analysts' Ratings History for Second Sight Medical Products (NASDAQ:EYES)
Show:
DateFirmActionRatingPrice TargetDetails
7/26/2016Rodman & RenshawReiterated RatingBuy$16.00View Rating Details
2/23/2016HC WainwrightReiterated RatingBuy$21.00View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Second Sight Medical Products (NASDAQ:EYES)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016        
7/28/2016Q216($0.15)($0.17)$2.66 million$1.04 millionViewListenView Earnings Details
4/28/2016Q116($0.16)($0.13)$1.38 million$1.05 millionViewListenView Earnings Details
3/3/2016Q415($0.14)($0.13)$2.47 million$2.40 millionViewN/AView Earnings Details
10/29/2015Q315($0.14)($0.13)$2.05 million$2.23 millionViewListenView Earnings Details
8/4/2015Q215($0.14)($0.14)$1.73 million$2.70 millionViewN/AView Earnings Details
5/13/2015Q115($0.12)$1.70 millionViewListenView Earnings Details
3/11/2015Q414($0.17)$1.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Second Sight Medical Products (NASDAQ:EYES)
Current Year EPS Consensus Estimate: $-0.62 EPS
Next Year EPS Consensus Estimate: $-0.59 EPS

Dividends

Dividend History for Second Sight Medical Products (NASDAQ:EYES)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Second Sight Medical Products (NASDAQ:EYES)
Insider Ownership Percentage: 34.70%
Institutional Ownership Percentage: 6.88%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/3/2016Edward David RandolphVPSell5,104$4.01$20,467.04View SEC Filing  
6/2/2016Robert J GreenbergChairmanSell8,571$4.10$35,141.10View SEC Filing  
4/18/2016Robert J GreenbergChairmanSell8,223$5.27$43,335.21View SEC Filing  
12/7/2015Robert J. GreenbergChairmanSell17,969$5.30$95,235.70View SEC Filing  
12/4/2015Anne-Marie Juliette RipleyVPSell2,500$5.50$13,750.00View SEC Filing  
6/4/2015Anne-Marie Juliette RipleyVPSell4,371$15.00$65,565.00View SEC Filing  
6/3/2015Robert J GreenbergCEOSell150,000$14.04$2,106,000.00View SEC Filing  
5/27/2015Anne-Marie Juliette RipleyVPSell45,629$13.04$595,002.16View SEC Filing  
3/23/2015Robert J GreenbergCEOSell100,000$13.28$1,328,000.00View SEC Filing  
11/19/2014Gregg WilliamsDirectorBuy111,111$9.00$999,999.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Second Sight Medical Products (NASDAQ:EYES)
DateHeadline
investornewswire.com logoShares Of Second Sight Medical Products, Inc. (NASDAQ:EYES) Expected To Hit $16 - Investor Newswire (NASDAQ:EYES)
www.investornewswire.com - September 21 at 9:10 AM
capitalcube.com logoETF’s with exposure to Second Sight Medical Products, Inc. : September 20, 2016 (NASDAQ:EYES)
www.capitalcube.com - September 21 at 9:10 AM
4-traders.com logoSecond Sight Medical Products : Patent Issued for Flexible Circuit Electrode Array Embedded in a Cured Body (USPTO 9427582) (NASDAQ:EYES)
www.4-traders.com - September 9 at 4:48 PM
News IconStock Struggling for the Quarter: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Post News (NASDAQ:EYES)
www.kentuckypostnews.com - September 4 at 4:37 PM
News IconRetinal Implant Market Is Anticipated To Witness Significant Growth By 2022: Hexa Reports (NASDAQ:EYES)
www.abnewswire.com - September 3 at 4:35 PM
finance.yahoo.com logoSecond Sight to Present at the Rodman & Renshaw 18th … (NASDAQ:EYES)
finance.yahoo.com - September 3 at 9:40 AM
businesswire.com logoSecond Sight to Present at the Rodman & Renshaw 18 th Annual Global Investment Conference on September 13, 2016 - Business Wire (press release) (NASDAQ:EYES)
www.businesswire.com - September 2 at 4:53 PM
News IconSecond Sight to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016 - Digital Journal (NASDAQ:EYES)
www.digitaljournal.com - September 2 at 9:49 AM
finance.yahoo.com logoSecond Sight to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016 (NASDAQ:EYES)
finance.yahoo.com - September 2 at 9:49 AM
capitalcube.com logoETF’s with exposure to Second Sight Medical Products, Inc. : August 31, 2016 (NASDAQ:EYES)
www.capitalcube.com - August 31 at 4:51 PM
News IconEarnings Preview: Second Sight Medical Products (NASDAQ:EYES) moved down 4 times out of last 5 quarters - The Independent Republic (NASDAQ:EYES)
theindependentrepublic.com - August 27 at 4:42 PM
News IconEarnings Preview: Second Sight Medical Products, Inc. (NASDAQ:EYES) moved down 4 times out of last 5 quarters - The Independent Republic (NASDAQ:EYES)
theindependentrepublic.com - August 26 at 5:48 AM
investornewswire.com logoSecond Sight Medical Products, Inc. (NASDAQ:EYES) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:EYES)
www.investornewswire.com - August 24 at 5:15 AM
News IconNavy Veteran blind for 19 years sees hope again (NASDAQ:EYES)
www.blogs.va.gov - August 20 at 4:53 PM
capitalcube.com logoETF’s with exposure to Second Sight Medical Products, Inc. : August 18, 2016 (NASDAQ:EYES)
www.capitalcube.com - August 18 at 10:18 PM
finance.yahoo.com logoSECOND SIGHT MEDICAL PRODUCTS INC Financials (NASDAQ:EYES)
finance.yahoo.com - August 17 at 5:09 PM
investornewswire.com logoWill Second Sight Medical Products, Inc. (NASDAQ:EYES) Hit $16 Price Target? - Investor Newswire (NASDAQ:EYES)
www.investornewswire.com - August 17 at 5:19 AM
capitalcube.com logoETF’s with exposure to Second Sight Medical Products, Inc. : August 8, 2016 (NASDAQ:EYES)
www.capitalcube.com - August 8 at 5:05 PM
biz.yahoo.com logoSECOND SIGHT MEDICAL PRODUCTS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:EYES)
biz.yahoo.com - August 8 at 5:05 PM
capitalcube.com logoSecond Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:EYES)
www.capitalcube.com - August 5 at 5:02 PM
fortune.com logoSecond Sight Medical Products, Inc. (NASDAQ:EYES) Stock Declines, Analysts: Hold Rating - Review Fortune (NASDAQ:EYES)
reviewfortune.com - July 31 at 4:44 PM
streetinsider.com logoSecond Sight Medical (EYES) Announces Distribution Agreements to Bring the Argus II Retinal Prosthesis to Taiwan and Iran (NASDAQ:EYES)
www.streetinsider.com - July 29 at 11:59 AM
News IconEarnings: Public Storage, Second Sight (NASDAQ:EYES)
www.sfvbj.com - July 28 at 9:26 PM
tmcnet.com logoSecond Sight Announces Two Exclusive Distribution Agreements to Bring the Argus II Retinal Prosthesis to Taiwan and Iran (NASDAQ:EYES)
www.tmcnet.com - July 28 at 9:26 PM
News IconSecond Sight Reports Second Quarter 2016 Financial Results (NASDAQ:EYES)
www.enhancedonlinenews.com - July 28 at 9:26 PM
4-traders.com logoSecond Sight Medical Products : Announces Two Exclusive Distribution Agreements to Bring the Argus II Retinal Prosthesis to Taiwan and Iran (NASDAQ:EYES)
www.4-traders.com - July 28 at 9:26 PM
sg.finance.yahoo.com logoSecond Sight Medical Products posts 2Q loss (NASDAQ:EYES)
sg.finance.yahoo.com - July 28 at 6:26 PM
biz.yahoo.com logoQ2 2016 Second Sight Medical Products Inc Earnings Release - After Market Close (NASDAQ:EYES)
biz.yahoo.com - July 28 at 7:07 AM
streetupdates.com logoAnalysts Update on Stocks: Boston Scientific Corporation (NYSE:BSX) , Second Sight Medical Products, Inc. (NASDAQ ... - Street Updates (NASDAQ:EYES)
www.streetupdates.com - July 26 at 5:00 PM
investornewswire.com logoCan Shares Of Second Sight Medical Products, Inc. (NASDAQ:EYES) Hit $16? - Investor Newswire (NASDAQ:EYES)
www.investornewswire.com - July 26 at 5:00 PM
News IconAnalyst Review: Second Sight Medical Products, Inc. (NASDAQ:EYES) - News Oracle (NASDAQ:EYES)
www.newsoracle.com - July 26 at 5:00 PM
smarteranalyst.com logoCompany Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Positive Five-Year Data from ... - Smarter Analyst (NASDAQ:EYES)
www.smarteranalyst.com - July 26 at 6:32 AM
fortune.com logoAnalysts: Second Sight Medical Products, Inc. (NASDAQ:EYES) stock is worth $16 - Review Fortune (NASDAQ:EYES)
reviewfortune.com - July 24 at 9:28 AM
News IconSecond Sight Medical Products Inc (NASDAQ:EYES)'s Company Shares Increased 8.82% After Low Volatility - Consumer Eagle (NASDAQ:EYES)
www.consumereagle.com - July 23 at 9:02 AM
smarteranalyst.com logoRodman & Renshaw Comments on Second Sight Medical Products Inc (EYES) Following Positive Five-Year Data for ... - Smarter Analyst (NASDAQ:EYES)
www.smarteranalyst.com - July 23 at 9:02 AM
4-traders.com logoSecond Sight Medical Products : Announces Positive Five-Year Data from Argus II Retinal Prosthesis System (NASDAQ:EYES)
www.4-traders.com - July 21 at 10:28 PM
streetinsider.com logoSecond Sight Medical (EYES) Reports Positive Five-Year Data for Argus II - StreetInsider.com (NASDAQ:EYES)
www.streetinsider.com - July 21 at 5:08 PM
news.cmlviz.com logoSecond Sight Medical Products Inc (NASDAQ:EYES) Stock Volatility Hits An Extreme High - CML News (NASDAQ:EYES)
news.cmlviz.com - July 21 at 5:08 PM
finance.yahoo.com logo4:06 pm Second Sight Medical Products announces five-year data from Argus II Retinal Prosthesis System (NASDAQ:EYES)
finance.yahoo.com - July 21 at 4:06 PM
finance.yahoo.com logoSecond Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System (NASDAQ:EYES)
finance.yahoo.com - July 21 at 4:05 PM
investornewswire.com logoIs $16 Price Target Attainable For Second Sight Medical Products, Inc. (NASDAQ:EYES)? - Investor Newswire (NASDAQ:EYES)
www.investornewswire.com - July 20 at 6:37 AM
News IconShares Experiencing a Downtrend: Second Sight Medical Products, Inc. (NASDAQ:EYES) - TGP (NASDAQ:EYES)
telanaganapress.com - July 16 at 8:21 AM
News IconSecond Sight Medical Products Inc Stock Price Declines Today - Consumer Eagle (NASDAQ:EYES)
www.consumereagle.com - July 15 at 6:50 AM
News IconShare Volatility Watch for: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily (NASDAQ:EYES)
www.engelwooddaily.com - July 13 at 5:16 PM
News IconSession Volatility Review for: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily (NASDAQ:EYES)
www.engelwooddaily.com - July 13 at 6:56 AM
investornewswire.com logoStrong Sell Calls For Second Sight Medical Products, Inc. (NASDAQ:EYES) At 0 - Investor Newswire (NASDAQ:EYES)
www.investornewswire.com - July 13 at 6:56 AM
fiscalstandard.com logoSecond Sight Medical Products, Inc. (EYES) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:EYES)
www.fiscalstandard.com - July 12 at 9:19 AM
News IconStock Moving Up in Trading: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Telanagana Press (NASDAQ:EYES)
telanaganapress.com - July 7 at 10:08 PM
News IconHeightened Volatility Check on: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily (NASDAQ:EYES)
www.engelwooddaily.com - July 7 at 10:08 PM
News IconFollowing Unusual Volume for: Second Sight Medical Products, Inc. (NASDAQ:EYES) - Engelwood Daily (NASDAQ:EYES)
www.engelwooddaily.com - July 7 at 10:08 PM

Social

Second Sight Medical Products (NASDAQ:EYES) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff